Clinical Research

IDRF operates as a Site Management Office (SMO) for the conduct of Clinical Trials in Diabetes / Cardio vascular Disease / Hypertension.

Salient Features of the SMO

  • Well equipped local lab facility
  • Experienced Site Coordinators
  • Facility to conduct Phase –II / III / IV Trials
  • Secure Drug Storage Area
  • Secure Document Storage Area
  • Archival Facility
  • Electronic Medical Records
  • Facility for EDC / IVRS
  • High – Speed Internet

Trials Completed:

Phase – III: 06
Phase – IV: 07

    • SIBA - Study on Soluble Insulin Basal Glargine

An open label, global, multicentric study to compare the efficacy and safety of 3 different insulin dosing regimens of Soluble Insulin Basal Glargine / insulin glargine with or without oral drugs.ClinicalTrials.gov Identifier: NCT01006291

    • ORIGIN: Outcome reduction with Initial Glargine Intervention

A major global multicentric study to evaluate the effects of Insulin glargine in combination with omega 3 fatty acids in reducing CV morbidity and mortalityin people at high risk ot at early stages of diabetes.ClinicalTrials.gov Identifier: NCT00069784

    • IDMPS: International Diabetes Management Practices Study – WAVE 5

An international, multicentric study to assess current practices in the management of type 1 and type 2 diabetes mellitus.